Endothelial progenitor cells, atheroma burden and clinical outcome in patients with coronary artery disease

Heart

Volumn 99, Issue 11, 2013, Pages 791-798

  Padfield, Gareth J ^a   Tura Ceide, Olga ^b   Freyer, Elizabeth ^a   Barclay, George Robin ^b   Turner, Marc ^b   Newby, David E ^a   Mills, Nicholas L ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN RECEPTOR; CD133 ANTIGEN; CD34 ANTIGEN; VASCULOTROPIN RECEPTOR 2;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROMA; CELL POPULATION; COLONY FORMING UNIT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; ENDOTHELIAL PROGENITOR CELL; FEMALE; FLOW CYTOMETRY; GENSINI SCORE; HEART MUSCLE NECROSIS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MONOCYTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; REVASCULARIZATION; STABLE ANGINA PECTORIS; STEM CELL; SURVIVAL;

ENDOTHELIUM;

ANTIGENS, CD34; ANTIGENS, CD45; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; DISEASE-FREE SURVIVAL; ENDOTHELIUM, VASCULAR; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; IMMUNITY, CELLULAR; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PLAQUE, ATHEROSCLEROTIC; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84877597840     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-302949     Document Type: Article

References (28)

1. Delewi R, Andriessen A, Tijssen JG, et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a meta-analysis of randomised controlled clinical trials. Heart 2013;99:4225-232.
2. Cheng J, Baumhueter S, Cacalano G, et al. Hematopoietic defects in mice lacking the sialomucin CD34. Blood 1996;87:479-90. (Pubitemid 26030303)
3. Shalaby F, Rossant J, Yamaguchi TP, et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995;376:62-6.
4. Yang C, Zhang ZH, Li ZJ, et al. Enhancement of neovascularization with cord blood CD133+ cell-derived endothelial progenitor cell transplantation. Thromb Haemost 2004;91:1202-12. (Pubitemid 38821278)
5. Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood 2000;95:952-8. (Pubitemid 30062717)
6. Shintani S, Murohara T, Ikeda H, et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001;103:2776-9. (Pubitemid 32550062)
7. Gill M, Dias S, Hattori K, et al. Vascular trauma induces rapid but transient mobilization of VEGFR2 (+) AC133 (+) endothelial precursor cells. Circ Res 2001;88:167-74. (Pubitemid 32147304)
8. Werner N, Priller J, Laufs U, et al. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol 2002;22:1567-72.
9. Takamiya M, Okigaki M, Jin D, et al. Granulocyte colony-stimulating factor-mobilized circulating c-Kit+/Flk-1+ progenitor cells regenerate endothelium and inhibit neointimal hyperplasia after vascular injury. Arterioscler Thromb Vasc Biol 2006;26:751-7. (Pubitemid 43732147)
10. Werner N, Kosiol S, Schiegl T, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005;353:999-1007. (Pubitemid 41262334)
11. Gehling UM, Ergun S, Schumacher U, et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000;95:3106-12. (Pubitemid 30321161)
12. Timmermans F, Van Hauwermeiren F, De Smedt M, et al. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors. Arterioscler Thromb Vasc Biol 2007;27:1572-9. (Pubitemid 46986112)
13. Case J, Mead LE, Bessler WK, et al. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 2007;35:1109-18. (Pubitemid 46921310)
14. Rehman J, Li J, Orschell CM, et al. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003;107:1164-9. (Pubitemid 36297209)
15. Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593-600. (Pubitemid 36204953)
16. Ringqvist I, Fisher LD, Mock M, et al. Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). J Clin Invest 1983;71:1854-66. (Pubitemid 13056789)
17. Padfield GJ, Tura O, Haeck ML, et al. Circulating endothelial progenitor cells are not affected by acute systemic inflammation. Am J Physiol Heart Circ Physiol 2010;298:H2054-61.
18. Hill JM, Zalos G, Halcox JPJ, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Eng J Med 2003;348:593-600. (Pubitemid 36204953)
19. Mills NL, Churchhouse AM, Lee KK, et al. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA 2011;305:1210-16.
20. Mills NL, Tura O, Padfield GJ, et al. Dissociation of phenotypic and functional endothelial progenitor cells in patients undergoing percutaneous coronary intervention. Heart 2009;95:2003-8.
21. Wojakowski W, Tendera M, Michalowska A, et al. Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 2004;110:3213-20. (Pubitemid 39525068)
22. Massa M, Rosti V, Ferrario M, et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 2005;105:199-206. (Pubitemid 40053083)
23. Guven H, Shepherd RM, Bach RG, et al. The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. J Am Coll Cardiol 2006;48:1579-87. (Pubitemid 44528190)
24. Fina L, Molgaard HV, Robertson D, et al. Expression of the CD34 gene in vascular endothelial cells. Blood 1990;75:2417-26. (Pubitemid 20202322)
25. Friedrich EB, Walenta K, Scharlau J, et al. CD34-/CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circ Res 2006;98:e20-5.
26. Bruno S, Bussolati B, Scacciatella P, et al. Combined administration of G-CSF and GM-CSF stimulates monocyte-derived pro-angiogenic cells in patients with acute myocardial infarction. Cytokine 2006;34:56-65. (Pubitemid 43817553)
27. Hu T, She Q, Jiang Y, et al. Level of CD14 (+)-endothelial progenitor cells is not associated with coronary artery disease or cardiovascular risk factors. AGE 2008;30:319-26.
28. Muller P, Kazakov A, Jagoda P, et al. ACE inhibition promotes upregulation of endothelial progenitor cells and neoangiogenesis in cardiac pressure overload. Cardiovasc Res 2009;83:106-14.